|

Administration of CC-3 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • German Cancer Research Center1

Indications

  • Penile Carcinoma1
  • Sarcoma1
  • Breast Carcinoma1
  • Colorectal Cancer1
  • Breast Cancer1

Other1 trial

FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.